Search research articles
Contact Us
Filters
Showing results (861-870 of 882) with videos related to
Page
of 89
Sort By:
Cell Discovery
|
October 24, 2022
A cluster of mesopontine GABAergic neurons suppresses REM sleep and curbs cataplexy
Ze-Ka Chen, Hui Dong, Cheng-Wei Liu, et al.
Cell Communication and Signaling : CCS
|
July 21, 2023
P38-DAPK1 axis regulated LC3-associated phagocytosis (LAP) of microglia in an in vitro subarachnoid hemorrhage model
Xiang-Xin Chen, Tao Tao, Xun-Zhi Liu, et al.
Cancer Chemotherapy and Pharmacology
|
August 4, 2017
Phase I study of veliparib in combination with gemcitabine
Ronald Stoller, John C Schmitz, Fei Ding, et al.
Nature Communications
|
November 25, 2015
Gekko japonicus genome reveals evolution of adhesive toe pads and tail regeneration
Yan Liu, Qian Zhou, Yongjun Wang, et al.
ACS Applied Materials & Interfaces
|
December 6, 2018
Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating
Lei Zhang, Xiao Yu Tian, Cecilia K W Chan, et al.
Breast Cancer Research and Treatment
|
February 28, 2023
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)
Monica K Malhotra, Shalu Pahuja, Brian F Kiesel, et al.
Annals of the American Thoracic Society
|
July 21, 2021
Association between ARDS Etiology and Risk of Noninvasive Ventilation Failure
Weiwei Shu, Shuliang Guo, Fuxun Yang, et al.
Organic Letters
|
August 9, 2014
A highly concise and convergent synthesis of HCV polymerase inhibitor Deleobuvir (BI 207127): application of a one-pot borylation-Suzuki coupling reaction
Yongda Zhang, Bruce Z Lu, Guisheng Li, et al.
Cancer Chemotherapy and Pharmacology
|
September 25, 2019
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Leonard J Appleman, Jan H Beumer, Yixing Jiang, et al.
Molecular & Cellular Proteomics : MCP
|
April 15, 2026
Plasma proteomic profiling was used to discover a biochemical recurrence prediction model for prostate cancer
Ning Xu, Linhui Zhang, Zhenmei Yao, et al.
Page
of 89
Search research articles
Search
Showing results (861-870 of 882) with videos related to
Sort By:
Page
of 89
Cell Discovery
|
October 24, 2022
A cluster of mesopontine GABAergic neurons suppresses REM sleep and curbs cataplexy
Ze-Ka Chen, Hui Dong, Cheng-Wei Liu, et al.
Cell Communication and Signaling : CCS
|
July 21, 2023
P38-DAPK1 axis regulated LC3-associated phagocytosis (LAP) of microglia in an in vitro subarachnoid hemorrhage model
Xiang-Xin Chen, Tao Tao, Xun-Zhi Liu, et al.
Cancer Chemotherapy and Pharmacology
|
August 4, 2017
Phase I study of veliparib in combination with gemcitabine
Ronald Stoller, John C Schmitz, Fei Ding, et al.
Nature Communications
|
November 25, 2015
Gekko japonicus genome reveals evolution of adhesive toe pads and tail regeneration
Yan Liu, Qian Zhou, Yongjun Wang, et al.
ACS Applied Materials & Interfaces
|
December 6, 2018
Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating
Lei Zhang, Xiao Yu Tian, Cecilia K W Chan, et al.
Breast Cancer Research and Treatment
|
February 28, 2023
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)
Monica K Malhotra, Shalu Pahuja, Brian F Kiesel, et al.
Annals of the American Thoracic Society
|
July 21, 2021
Association between ARDS Etiology and Risk of Noninvasive Ventilation Failure
Weiwei Shu, Shuliang Guo, Fuxun Yang, et al.
Organic Letters
|
August 9, 2014
A highly concise and convergent synthesis of HCV polymerase inhibitor Deleobuvir (BI 207127): application of a one-pot borylation-Suzuki coupling reaction
Yongda Zhang, Bruce Z Lu, Guisheng Li, et al.
Cancer Chemotherapy and Pharmacology
|
September 25, 2019
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Leonard J Appleman, Jan H Beumer, Yixing Jiang, et al.
Molecular & Cellular Proteomics : MCP
|
April 15, 2026
Plasma proteomic profiling was used to discover a biochemical recurrence prediction model for prostate cancer
Ning Xu, Linhui Zhang, Zhenmei Yao, et al.
Page
of 89